Chardan Serves as Lead Manager for LogicBio Therapeutics

Tuesday, October 23, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 22, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as lead manager

in the initial public offering of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), raising aggregate gross proceeds of approximately $70.0 million. LogicBio began trading on the NASDAQ Capital Market on October
19, 2018
.

Chardan has participated in advisory and capital raising transactions totaling more than $2 billion in 2018.

About Chardan

Chardan is an independent global investment bank specializing in healthcare, SPACs and emerging growth companies. Our range of services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc.

Learn more about Chardan: www.chardan.com

Media Contact: Emily Levine, Chardan elevine@chardan.com  (646) 465-9018

Tom Rozycki, Prosek Partnerstrozycki@prosek.com (646) 503-5657

Cision View original content:http://www.prnewswire.com/news-releases/chardan-serves-as-lead-manager-for-logicbio-therapeutics-300735489.html

SOURCE Chardan Capital Markets, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store